/ Kills / FAT KILL
FAT KILL
“Not a diet. A vendetta.”
// 01
Summary.
Clinician-gated metabolic protocol. GLP-R agonists plus a GH-fragment adjunct. This lane is NPI-gated referral only — killer.health publishes the framework and the registry data, not the prescription.
Dosing card pending clinician sign-off. Titration schedules for GLP-R agonists are individual, dose-escalated, and prescriber-managed. We are not publishing a unit-by-unit card for this protocol. Work with your prescriber.
// 02
The stack.
Peptide · 01
TIRZ
Dual GIP / GLP-R agonist
Prescriber-managed titration. NPI-gated.
clinician lane
Peptide · 02
RETA
Triple-agonist GLP-R class
Prescriber-managed titration. NPI-gated.
clinician lane
Peptide · 03
AOD-9604
hGH fragment (176-191)
Targets fat metabolism without raising IGF-1 or blood sugar.
2 mg / vial
// 03
Reconstitution.
AOD-9604 · 2 mg vial + 2 mL bac water
250–300 mcg daily · 25–30 units on a U-100
Morning, empty stomach.
GLP-R agonists (TIRZ / RETA):
Titration is prescriber-managed. No public dosing card.
Ask your clinician. Start low, escalate slowly, monitor.
// 04
Dosing table.
| Level | Stack | Units (U-100) | Freq |
|---|---|---|---|
| ADJUNCT | AOD-9604 | 25–30 | Daily AM, fasted |
| CLINICIAN | TIRZ / RETA | prescriber-set | Weekly · titrated |
Per-compound vial math: AOD-9604
// 05
Cycle & timing.
ON
12 WEEKS
With labs at baseline, week 6 and week 12. Protein intake and resistance training are not optional on this protocol.
OFF
PRESCRIBER-SET
Discontinuation and maintenance are clinical decisions, not forum decisions.
// 06
Contraindications.
- —Personal or family history of medullary thyroid carcinoma or MEN2 — hard stop for the GLP-R class.
- —Pregnancy / lactation.
- —Active pancreatitis or gallbladder disease.
- —Severe gastroparesis or other significant GI motility disorder.
- —Eating-disorder history — screen first, always.
- —This lane requires a prescriber. Do not self-source.
// 07
Evidence.
CLINICAL
The GLP-R class has the largest randomized-trial base of anything on this site. That is exactly why it belongs in the clinician lane and not in a kitchen-counter dosing card.
AOD-9604
hGH fragment data is preclinical-heavy with limited human trials. Treated here as an adjunct, not a primary agent.
REGISTRY
Outcome and adverse-event capture on this protocol is the highest-value data the registry collects. Log your cycle.
// 09
Adverse events.
MILD
0
MODERATE
0
SEVERE
0
// 10
Related kills.
RECOVERY KILL
“Heal like you borrowed the body.”
SLEEP KILL
“Die better at night.”
LONGEVITY KILL
“Outlive your enemies.”
// Disclaimer
Nothing on killer.health is medical advice. This platform is a research registry and information aggregator. Content is drawn from peer-reviewed publications, clinical protocols and community sources. killer.health does not endorse any compound, supplier or treatment. Always work with a licensed physician inside an established clinical relationship before starting, stopping or modifying any protocol. Data capture is governed by IRB PPRN-001-2025. Anonymous submissions are the default.